Transform Pharmaceutical Authoring Processes With Fonto Integrated Authoring Platform
RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces the launch of the Fonto Integrated Authoring Platform (IAP), a game-changing solution designed to streamline the document creation and publishing process for the pharmaceutical industry.
- RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces the launch of the Fonto Integrated Authoring Platform (IAP), a game-changing solution designed to streamline the document creation and publishing process for the pharmaceutical industry.
- “We’re delighted to announce the availability of Fonto IAP,” explains Jan Benedictus, Managing Director, Fonto.
- That’s why we’ve introduced Fonto IAP,” according to a Digital Transformation Program Lead at a large pharmaceutical company.
- Fonto and Tridion are part of RWS’s structured authoring and content management portfolio of solutions.